Riskpilot← Back to searchSign inGet full accessZ Sadlon Läkarkonsult AB
ABActiveOrg 5592731136Valdemarsrovägen 5General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
—
0 employees
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
Z Sadlon Läkarkonsult AB
Org number
5592731136
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
24 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Sjukvård, konsultverksamhet framförallt inom primärvård. Förvaltning av värdepapper samt fastigheter.
Address
Valdemarsrovägen 5
Email
zofiasadlon@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 138 | 272 | 376 | 514 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | 115 | 252 | 339 | 478 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 115 | 252 | 339 | 478 | 0 |
| Net financials | — | — | — | 6 | — |
| Profit before tax | 115 | 252 | 339 | 484 | 0 |
| Tax | −25 | −52 | −70 | −99 | — |
| Net profit | 90 | 200 | 269 | 385 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 198 | 420 | 553 | 817 | — |
| Equity | 115 | 225 | 305 | 490 | — |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 82 | 195 | 248 | 327 | — |
| Total debt | 82 | 195 | 248 | 327 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-09-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Z Sadlon Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Grazyna Zofia Sadlon | Board of Directors | 0 companies |
| Mikael Kaj Sadlon | Deputy Board Member | 0 companies |